Mettler-Toledo International (NYSE:MTD) Releases Q4 2025 Earnings Guidance

Mettler-Toledo International (NYSE:MTD) updated its fourth quarter 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 12.680-12.880 for the period, compared to the consensus estimate of 13.120. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Mettler-Toledo International also updated its FY 2025 guidance to 42.050-42.250 EPS.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Robert W. Baird raised their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a report on Monday, August 4th. JPMorgan Chase & Co. raised their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a report on Thursday, October 9th. Citigroup raised their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Thursday, August 21st. Bank of America raised their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Finally, Evercore ISI raised their target price on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $1,336.50.

Mettler-Toledo International Trading Up 0.2%

Shares of MTD traded up $2.69 on Thursday, reaching $1,442.42. 210,956 shares of the company’s stock traded hands, compared to its average volume of 165,587. The stock has a market cap of $29.71 billion, a PE ratio of 36.53, a PEG ratio of 4.19 and a beta of 1.41. The stock’s 50 day simple moving average is $1,314.61 and its two-hundred day simple moving average is $1,230.51. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,454.68.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating analysts’ consensus estimates of $10.63 by $0.52. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company’s stock, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 165 shares of the firm’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the sale, the insider directly owned 94 shares of the company’s stock, valued at $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is owned by insiders.

Institutional Trading of Mettler-Toledo International

A number of large investors have recently bought and sold shares of MTD. State of Wyoming purchased a new stake in Mettler-Toledo International in the second quarter worth $58,000. MUFG Securities EMEA plc purchased a new stake in Mettler-Toledo International in the second quarter worth $72,000. Geneos Wealth Management Inc. increased its position in Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 30 shares during the last quarter. Benjamin Edwards Inc. increased its position in Mettler-Toledo International by 4.8% in the second quarter. Benjamin Edwards Inc. now owns 218 shares of the medical instruments supplier’s stock worth $256,000 after buying an additional 10 shares during the last quarter. Finally, EP Wealth Advisors LLC purchased a new stake in Mettler-Toledo International in the second quarter worth $282,000. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.